Home Medicine Delayed diagnosis of proopiomelanocortin (POMC) deficiency with type 1 diabetes in a 9-year-old girl and her infant sibling
Article
Licensed
Unlicensed Requires Authentication

Delayed diagnosis of proopiomelanocortin (POMC) deficiency with type 1 diabetes in a 9-year-old girl and her infant sibling

  • Elif Ozsu EMAIL logo and Allison Bahm
Published/Copyright: September 15, 2017

Abstract

Background:

Proopiomelanocortin (POMC) protein, encoded by the POMC gene, is the precursor of adrenocorticotropic hormone (ACTH) that is released from the anterior pituitary gland. Homozygous mutations in the POMC gene is associated with hyperphagia, severe and early-onset obesity, adrenal insufficiency, hypopigmentation of the skin and red hair.

Case presentation:

A 9-year-old girl from a consanguineous family of Iraqi origin was diagnosed with type 1 diabetes. She also had a tall stature. Her laboratory assessment showed low cortisol and ACTH concentrations, normal renin and poor response to ACTH stimulation. Genetic testing revealed a novel biallelic mutation in the POMC gene. Her sibling who had severe obesity and central adrenal insufficiency was found to be a carrier of the same mutation. Both siblings had alabaster-colored skin and brown hair.

Conclusions:

POMC deficiency results in significant morbidity due to obesity, and it is also a potentially life threatening disease because of adrenal insufficiency. Therefore any suggestive symptom or sign of POMC deficiency warrants detailed investigations.


Corresponding author: Elif Ozsu, MD, Pediatric Endocrinology, Samsun Obstetrics and Children Hospital, Samsun, Turkey, Phone: +90 505 454 75 89, Fax: +90 362 230 91 00

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Farooqi IS, Drop S, Clements A, Keogh JM, Biernacka J, et al. Heterozygosity for a POMC-null mutation and increased obesity risk in humans. Diabetes 2006;55:2549–53.10.2337/db06-0214Search in Google Scholar PubMed

2. Cirillo G, Marini R, Ito S, Wakamatsu K, Scianguetta S, et al. Lack of red hair phenotype in a North-African obese child homozygous for a novel POMC null mutation: nonsense-mediated decay RNA evaluation and hair pigment chemical analysis. Br J Dermatol 2012;167:1393–5.10.1111/j.1365-2133.2012.11060.xSearch in Google Scholar PubMed

3. Aslan IR, Ranadive SA, Valle I, Kollipara S, Noble JA, et al. The melanocortin system and insulin resistance in humans: insights from a patient with complete POMC deficiency and type 1 diabetes mellitus. Int J Obes (Lond) 2014;38:148–51.10.1038/ijo.2013.53Search in Google Scholar PubMed PubMed Central

4. Coppari R, Bjorbaek C. Leptin revisited: its mechanism of action and potential for treating diabetes. Nat Rev Drug Discov 2012;11:692–708.10.1038/nrd3757Search in Google Scholar PubMed PubMed Central

5. Anisimova AS, Rubtsov PM, Akulich KA, Dmitriev SE, Flolova E, et al. Late Diagnosis of POMC Deficiency and in vitro evidence of residual translation from allele with c.-11C>A mutaion. J. Clin Endocrinol Metab 2017;102:359–62.Search in Google Scholar

Received: 2017-2-10
Accepted: 2017-7-24
Published Online: 2017-9-15
Published in Print: 2017-10-26

©2017 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. Individualised growth response optimisation (iGRO) tool: an accessible and easy-to-use growth prediction system to enable treatment optimisation for children treated with growth hormone
  4. Original Articles
  5. Relation of insulin resistance to neurocognitive function and electroencephalography in obese children
  6. Body weight misperception and health-related factors among Iranian children and adolescents: the CASPIAN-V study
  7. Do sufficient vitamin D levels at the end of summer in children and adolescents provide an assurance of vitamin D sufficiency at the end of winter? A cohort study
  8. Type 3 renal tubular acidosis associated with growth hormone deficiency
  9. Serum α-klotho levels are not informative for the evaluation of growth hormone secretion in short children
  10. Evaluation of neurodevelopment of children with congenital hypothyroidism by the Denver Developmental Screening Test
  11. Pediatric differentiated thyroid carcinoma: trends in practice and outcomes over 40 years at a single tertiary care institution
  12. Physical activity and bone mineral density at the femoral neck subregions in adolescents with Down syndrome
  13. A pilot study on the utility of reduced urine collection frequency protocols for the assessment of reproductive hormones in adolescent girls
  14. MODY in Ukraine: genes, clinical phenotypes and treatment
  15. A retrospective review of initial bisphosphonate infusion in an inpatient vs. outpatient setting for bisphosphonate naïve patients
  16. Molecular genetic and clinical delineation of 22 patients with congenital hypogonadotropic hypogonadism
  17. Letter to the Editor
  18. Rare cases of galactose metabolic disorders: identification of more than two mutations per patient
  19. Case Reports
  20. When one disease is not enough: succinyl-CoA: 3-oxoacid coenzyme A transferase (SCOT) deficiency due to a novel mutation in OXCT1 in an infant with known phenylketonuria
  21. Pseudohypoparathyroidism type 1B associated with assisted reproductive technology
  22. Long QT syndrome diagnosed in two sisters with propionic acidemia: a case report
  23. Delayed diagnosis of proopiomelanocortin (POMC) deficiency with type 1 diabetes in a 9-year-old girl and her infant sibling
Downloaded on 19.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2017-0064/pdf
Scroll to top button